$DXYZ

Destiny Tech100 Inc.

0
1
0

No SEC Form 4 filings for $DXYZ in the last 30 days.

See all $DXYZ insider activity →
Low

Retail Investors Are Chasing Anthropic Before an IPO. Does Destiny Tech100 Offer Exposure or a Premium Trap?

Retail investors are exploring Destiny Tech100 (DXYZ) for exposure to Anthropic before its IPO. DXYZ reported a net asset value of $34.30 per share in June, with a $235.7 million position in Anthropic. The fund also made additional investments in OpenAI and other private tech firms. Hedge-fund interest in DXYZ has increased, but the fund's market price may not reflect its underlying asset value accurately. Investors should monitor NAV, shares outstanding, and market price for informed decisions.

DXYZ, NASA, VCX Slip Overnight: SpaceX IPO Buyers Get Tiny Allocations, Rush To Take Profits

Shares of DXYZ, NASA, and VCX fell up to 3% overnight as retail investors received limited allocations in SpaceX's IPO. SpaceX's stock (SPCX) surged 20% on Monday, reaching a $2.5 trillion market cap. Leveraged long ETFs like SPCM and SPCL rose 22%, while bearish funds like SSPC and SPCQ dropped 30-36%. VCX was the biggest loser, falling 15%. Retail investors reported receiving far fewer shares than requested, with some taking profits.

How to Own SpaceX Without Buying the IPO

SpaceX filed an S-1 with the SEC on May 20, 2026 for a Nasdaq IPO, targeting a valuation of $1.75T–$2T and about 5% of the company in float. The filing shows 2025 revenue of $18B, with Starlink at $11.4B (61%); Starlink reported 10.3M paid subscriptions in Q1 2026 and connectivity income of $4.42B. The article highlights ETF exposure via XOVR and a closed-end fund (DXYZ), and also points to Rocket Lab’s Neutron contract and backlog.

DXYZ sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning DXYZ (Destiny Tech100 Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent DXYZ coverage spans financial news, market movers and ipo.

What's driving DXYZ

alphai scores every news story that mentions DXYZ with an AI model for sentiment and relevance, and aggregates insider trades from Destiny Tech100 Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $DXYZ

Score

Retail Investors Are Chasing Anthropic Before an IPO. Does Destiny Tech100 Offer Exposure or a Premium Trap?

Retail investors are exploring Destiny Tech100 (DXYZ) for exposure to Anthropic before its IPO. DXYZ reported a net asset value of $34.30 per share in June, with a $235.7 million position in Anthropic. The fund also made additional investments in OpenAI and other private tech firms. Hedge-fund interest in DXYZ has increased, but the fund's market price may not reflect its underlying asset value accurately. Investors should monitor NAV, shares outstanding, and market price for informed decisions.

DXYZ, NASA, VCX Slip Overnight: SpaceX IPO Buyers Get Tiny Allocations, Rush To Take Profits

Shares of DXYZ, NASA, and VCX fell up to 3% overnight as retail investors received limited allocations in SpaceX's IPO. SpaceX's stock (SPCX) surged 20% on Monday, reaching a $2.5 trillion market cap. Leveraged long ETFs like SPCM and SPCL rose 22%, while bearish funds like SSPC and SPCQ dropped 30-36%. VCX was the biggest loser, falling 15%. Retail investors reported receiving far fewer shares than requested, with some taking profits.

$DXYZMedAI 8/10

How to Own SpaceX Without Buying the IPO

SpaceX filed an S-1 with the SEC on May 20, 2026 for a Nasdaq IPO, targeting a valuation of $1.75T–$2T and about 5% of the company in float. The filing shows 2025 revenue of $18B, with Starlink at $11.4B (61%); Starlink reported 10.3M paid subscriptions in Q1 2026 and connectivity income of $4.42B. The article highlights ETF exposure via XOVR and a closed-end fund (DXYZ), and also points to Rocket Lab’s Neutron contract and backlog.

$DXYZMed

Michael Burry Compares OpenAI, SpaceX IPO Hype To Dot-Com Bubble - Destiny Tech100 (NYSE:DXYZ), Microsoft

Michael Burry compared current private-market enthusiasm for AI and space—citing OpenAI, Anthropic and SpaceX—to the dot-com bubble, pointing to a “National IPO Market Review” showing how IPO activity surged in 2000 before deteriorating. He linked the risk to concentrated hype and valuations, noting public proxies like Destiny Tech100 (DXYZ) and Microsoft (MSFT).

Destiny Tech100 (NYSE:DXYZ) Trading Down 9.7% – Time to Sell?

Destiny Tech100 Inc. (NYSE:DXYZ) fell 9.7% on Tuesday, trading between $55.00 and $60.19 versus a prior close of $66.64. Midday volume was 13.85M shares, up 461% from average. The stock is above its 50-day ($35.60) and 200-day ($30.87) moving averages. Institutional activity included new or increased stakes by Geneos Wealth, Sunbelt Securities, CWM, RBC, and Clearstead Trust.

$DXYZMed

Destiny Tech100 Gains on IPO Hopes for SpaceX

Destiny Tech100 Inc. (DXYZ) surged 18.1% after SpaceX's IPO filing drew attention to DXYZ's significant holding in SpaceX, which makes up 14.5% of its portfolio. DXYZ, a closed-end fund designed to give public investors exposure to private tech startups, traded at 2.3 times its net asset value. While the fund includes stakes in other private companies like Anthropic and OpenAI, critics warn about its high premium and opacity, especially if SpaceX's IPO faces delays or prices lower than expected.

$DXYZMed

Destiny Tech100 (NYSE:DXYZ) Shares Down 3.7% - Here's What Happened

Destiny Tech100 (NYSE:DXYZ) saw its share price drop by 3.7% during mid-day trading on Monday, with approximately 944,566 shares traded. The stock, which previously closed at $28.10, traded as low as $26.27 and last at $27.0540. Several institutional investors, including Stratos Wealth Partners LTD. and Jane Street Group LLC, recently adjusted their holdings in DXYZ.

$DXYZMed

Destiny Tech100 (NYSE:DXYZ) Trading Down 10.2% - Should You Sell?

Destiny Tech100 (NYSE:DXYZ) saw its stock price drop by 10.2% during mid-day trading, falling to $30.8160 on increased trading volume. Despite this decline, the stock remains above its 50-day and 200-day moving averages, and several institutional investors, including AA Financial Advisors and UBS Group AG, have recently increased or initiated positions, indicating continued institutional interest. While analysts currently rate DXYZ as a "Hold," MarketBeat suggests five other stocks that top analysts recommend as better buys.

$DXYZMed

Destiny Tech100 (NYSE:DXYZ) Stock Price Up 4.6% - What's Next?

Shares of Destiny Tech100 (NYSE:DXYZ) rose 4.6% on Monday, trading on significantly higher than average volume. The stock's price is currently above its 50-day and 200-day moving averages, indicating strong recent momentum. Several institutional investors have recently increased their holdings in DXYZ, including Aristides Capital opening a new stake and Invesco Ltd. growing its position by 84.9%.

Related tickers